Q3 2018 Holdings
Filed 2018-11-13 | 51 holdings | $210.4K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2018-11-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ReShape Lifesciences IncA | COM | 761123108 | $2 | 52,546 | 0.0% |
| Radius Health IncA | COM | 750469207 | $257 | 18,799 | 0.1% |
| Spark Therapeutics IncA | COM | 84652J103 | $502 | 12,000 | 0.2% |
| Amicus Therapeutics Inc(FOLD)A | COM | 03152W109 | $543 | 58,600 | 0.3% |
| Amicus Therapeutics Inc(ANAB) | COM | 032724106 | $543 | 58,600 | 0.3% |
| Spring Bk Pharmaceuticals IncA | COM | 849431101 | $673 | 73,000 | 0.3% |
| Corvus Pharmaceuticals Inc(CRVS)A | COM | 221015100 | $710 | 108,000 | 0.3% |
| Corvus Pharmaceuticals Inc(BIIB) | COM | 09062X103 | $710 | 108,000 | 0.3% |
| Paratek Pharmaceuticals IncA | COM | 699374302 | $766 | 103,500 | 0.4% |
| Supernus Pharmaceuticals Inc(SUPN)A | COM | 868459108 | $809 | 20,953 | 0.4% |
| Acadia Pharmaceuticals Inc(ACAD)A | COM | 004225108 | $1.0K | 65,000 | 0.5% |
| Horizon Pharma PlcA | SHS | G4617B105 | $1.0K | 69,000 | 0.5% |
| Horizon Pharma Plc | SHS | M46135105 | $1.0K | 69,000 | 0.5% |
| Merus N VA | COM | N5749R100 | $1.1K | 75,060 | 0.5% |
| Cymabay Therapeutics Inc(CBAYUSD)A | COM | 23257D103 | $1.2K | 145,000 | 0.6% |
| Globus Med Inc(ESPR) | COM | 29664W105 | $1.3K | 29,000 | 0.6% |
| Globus Med Inc(GMED)A | COM | 379577208 | $1.3K | 29,000 | 0.6% |
| GW Pharmaceuticals PlcA | ADS | 36197T103 | $1.3K | 9,600 | 0.6% |
| FibroGen Inc(FGENEUR)A | COM | 31572Q808 | $1.5K | 31,400 | 0.7% |
| FibroGen Inc(CLVSEUR) | COM | 189464100 | $1.5K | 31,400 | 0.7% |
| Sangamo Therapeutics Inc(SGMO)A | COM | 800677106 | $1.5K | 113,000 | 0.7% |
| Madrigal Pharmaceuticals Inc(MDGL)A | COM | 558868105 | $1.6K | 10,000 | 0.8% |
| Sutro Biopharma IncA | COM | 869367102 | $1.7K | 146,653 | 0.8% |
| Sage Therapeutics Inc(SG7)A | COM | 78667J108 | $1.7K | 15,996 | 0.8% |
| Sage Therapeutics Inc | COM | 68404V100 | $1.7K | 15,996 | 0.8% |
| Bluebird Bio Inc(AXGN) | COM | 05463X106 | $1.9K | 17,000 | 0.9% |
| Bluebird Bio IncA | COM | 09609G100 | $1.9K | 17,000 | 0.9% |
| Ionis Pharmaceuticals Inc(IONS)A | COM | 462222100 | $2.0K | 51,500 | 1.0% |
| Agios Pharmaceuticals Inc(AGIO)A | COM | 00847X104 | $2.2K | 36,500 | 1.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR)A | COM | 24344T101 | $2.3K | 77,000 | 1.1% |
| Intersect Ent IncA | COM | 46071F103 | $2.5K | 112,000 | 1.2% |
| Seattle Genetics IncA | COM | 812578102 | $2.5K | 42,500 | 1.2% |
| Seattle Genetics Inc | COM | 737010108 | $2.5K | 42,500 | 1.2% |
| Jazz Pharmaceuticals PLC(JAZZ)A | SHS USD | G50871105 | $2.8K | 21,600 | 1.3% |
| G1 Therapeutics Inc(GTHXEUR)A | COM | 3621LQ109 | $2.9K | 72,000 | 1.4% |
| Sarepta Therapeutics Inc(PEN) | COM | 70975L107 | $3.3K | 27,000 | 1.6% |
| Sarepta Therapeutics Inc(SRPT)A | COM | 803607100 | $3.3K | 27,000 | 1.6% |
| Neurocrine Biosciences Inc(NBIX)A | COM | 64125C109 | $3.3K | 35,500 | 1.6% |
| Shire plcA | SPONSORED ADR | 82481R106 | $3.5K | 25,000 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $3.5K | 52,800 | 1.7% |
| Spectrum Pharmaceuticals IncA | COM | 84763A108 | $3.9K | 300,000 | 1.8% |
| Zogenix IncA | COM | 98978L204 | $4.2K | 110,000 | 2.0% |
| Abiomed Inc(ABMDEUR)A | COM | 003654100 | $4.6K | 13,200 | 2.2% |
| Puma Biotechnology Inc(PBYI)A | COM | 74587V107 | $5.1K | 144,300 | 2.4% |
| Gilead Sciences Inc(GILD)A | COM | 375558103 | $5.3K | 90,284 | 2.5% |
| Kalvista Pharmaceuticals Inc(KALV)A | COM | 483497103 | $5.5K | 322,436 | 2.6% |
| Adamas Pharmaceuticals Inc(ADMSEUR)A | COM | 00548A106 | $5.7K | 370,000 | 2.7% |
| Aerie Pharmaceuticals Inc(AERIEUR)A | COM | 00771V108 | $5.9K | 125,179 | 2.8% |
| Halozyme Therapeutics Inc(HALO)A | COM | 40637H109 | $6.0K | 428,633 | 2.8% |
| Biomarin Pharmaceutical Inc | COM | 05366U100 | $7.2K | 97,284 | 3.4% |